Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’ Substack by Kontra. In this article, we will summarize the bull’s thesis on TEVA.
Teva Pharmaceutical Industries Ltd (TEVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ion Asset Management Stephen Levey And Jonathan Half | 39,033,500 | $599,944,895 | +7% | 38.81% |
| 2. | Rubric Capital Management David Rosen | 25,550,000 | $392,703,500 | +51% | 7.04% |
| 3. | Point State Capital Zach Schreiber | 15,131,488 | $232,570,971 | +12% | 3.37% |
| 4. | Glenview Capital Larry Robbins | 14,778,641 | $227,147,712 | +75% | 5.58% |
| 5. | Viking Global Andreas Halvorsen | 10,125,478 | $155,628,597 | +56% | 0.49% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.60 | 104,500 | $1,003,409.00 | 220,442 | 2019-06-04 | Filing | |
| $8.98 | 111,000 | $997,013.10 | 115,942 | 2019-06-03 | Filing | |
| $21.92 | 2,000 | $43,840.00 | 6,445 | 2018-08-03 | Filing | |
| $19.32 | 250,000 | $4,829,700.00 | 1,500,000 | 2018-05-10 | Filing | |
| $19.21 | 500,000 | $9,603,150.00 | 1,250,000 | 2018-05-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.08 | 55,775 | $952,464.10 | 403,288 | 2025-06-12 | Filing | |
| $17.02 | 6,206 | $105,627.98 | 9,989 | 2025-06-03 | Filing | |
| $18.04 | 337,915 | $6,097,304.47 | 150,996 | 2025-05-08 | Filing | |
| $15.90 | 48,385 | $769,369.89 | 48,384 | 2025-03-05 | Filing | |
| $15.91 | 22,576 | $359,272.21 | 96,769 | 2025-03-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 54,275 | $909,649 | 0.12% | |
| 2. | 10,000 | $167,600 | 0.01% | |
| 3. | 1 | $17 | 0% |
News See All
Goldman Sachs Starts Teva Pharma (TEVA) at Buy on Branded Drug Growth
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside potential.
Billionaire Stan Druckenmiller's 10 Stock Picks with Huge Upside Potential
Stanley Druckenmiller, an American billionaire investor, is the founder of Duquesne Capital.
Teva Pharmaceutical Industries Limited (TEVA) Highlights Long-Acting Injectable Advancements for Schizophrenia at 2025 Psych Congress
Teva Pharmaceutical Industries Limited (NYSE:TEVA) has unveiled new data at the 2025 Psych Congress Elevate, highlighting significant advances in schizophrenia treatment.
Teva Pharmaceutical Industries Limited (TEVA) Study Finds Gaps in Tardive Dyskinesia Care at Long-Term Facilities
A new study from Teva Pharmaceutical Industries Limited (NYSE:TEVA) has uncovered alarming gaps in the diagnosis and treatment of tardive dyskinesia (TD) among residents in long-term care (LTC) facilities...
Truist Initiates Teva Pharmaceuticals (TEVA) Coverage with Buy, $25 Price Target
Teva Pharma is an Israeli pharmaceutical company best known as one of the world’s largest manufacturers of generic drugs.
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408
Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced today that its investigational drug TEV-53408 has received Fast Track designation from the US Food and Drug Administration (FDA) for the treatment...
Regulatory Shake-Up Led to the Sell Off in Teva Pharmaceutical Industries Limited (TEVA)
Sound Shore Management, an investment management firm, has released its investor letter for the first quarter of 2025. A copy of the letter can be downloaded here.
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
10 Best Affordable Stocks Under $20 to Buy
On May 6, Paul Tudor Jones, Tudor Investment Corporation founder and CIO, and Robin Hood Foundation founder and board member, appeared on CNBC’s ‘Squawk Box’ to talk about Trump’s tariff policies...
Billionaire Hedge Funds
